Apolipoprotein A-I inhibits transformation of high density lipoprotein subpopulations during incubation of human plasma

      This paper is only available as a PDF. To read, Please Download here.


      We have examined the effect of added apolipoprotein A-I (apoA-I) on the changes in high density lipoprotein (HDL) particle size that occur when human plasma is incubated in vitro. In the absence of added apoA-I, incubation of plasma at 37°C resulted in a dramatic increase in HDL particle size. When these incubations contained an inhibitor of LCAT, an additional population of smaller HDL particles was formed. These changes in particle size were even more pronounced when the incubations were supplemented with an artificial triglyceride emulsion, Intralipid. All these changes in HDL particle size were markedly inhibited when incubations were supplemented with apoA-I. Even when the amount of added apoA-I was as little as 4.5% of the endogenous apolipoprotein there was an obvious inhibition of the changes in HDL particle size. The presence of added apoA-I sufficient to increase the plasma concentration by 18% virtually abolished the changes in HDL particle size. This effect did not relate to an inhibition of cholesterol esterification, nor did it appear to depend on an incorporation of the added apoA-I into the HDL.



      apoA-I, apolipoprotein A-I (), HDL, high density lipoproteins (), HDL2, HDL subfraction-2 (), HDL3, HDL subfraction-3 (), VLDL, very low density lipoproteins (), LCAT (), lecithin (), cholesterol acyltransferase (), PCMPS (), p-chloromercuriphenyl sulphonate ()
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Kostner G.M.
        Isolation, subfractionation, and characterization of human serum high-density lipoproteins.
        in: Day C.E. High Density Lipoproteins. Marcel-Dekker, New York1981: 1
        • Blanche P.J.
        • Gong E.L.
        • Forte T.M.
        • Nichols A.V.
        Characterization of human high-density lipoproteins by gradient gel electrophoresis.
        Biochim. Biophys. Acta. 1981; 665: 408
        • Daerr W.H.
        • Greten H.
        In vitro modulation of the distribution of normal human plasma high density lipoprotein subfractions through the lecithin: cholesterol acyltransferase reaction.
        Biochim. Biophys. Acta. 1981; 710: 128
        • Schmitz G.
        • Assmann G.
        • Melnik B.
        The role of lecithin: cholesterol acyltransferase in high density lipoprotein 3/high density lipoprotein 2 interconversion.
        Clin. Chim. Acta. 1981; 119: 225
        • Hopkins G.J.
        • Chang L.B.
        • Barter P.J.
        Role of lipid transfers in the formation of a subpopulation of small high density lipoproteins.
        J. Lipid Res. 1985; 26: 218
        • Patsch J.R.
        • Gotto Jr., A.M.
        • Olivecrona T.
        • Eisenberg S.
        Formation of high density lipoprotein2-like particles during lipolysis of very low density lipoproteins in vitro.
        in: 7th edn. Proc. Natl. Acad. Sci. USA. 75. 1978: 4519
        • Patsch J.R.
        • Prasad S.
        • Gotto Jr., A.M.
        • BengtssonOlivecrona G.
        Postprandial lipemia. A key for the conversion of high density lipoprotein2 into high density lipoprotein3 by hepatic lipase.
        J. Clin. Invest. 1984; 74: 2017
        • Hopkins G.J.
        • Barter P.J.
        Role of triglyceride-rich lipoproteins and hepatic lipase in determining the particle size and composition of high density lipoproteins.
        J. Lipid Res. 1986; 27: 1265
        • Gambert P.
        • Lallemant C.
        • Athias A.
        • Padieu P.
        Alterations of HDL cholesterol distribution induced by incubation of human serum.
        Biochim. Biophys. Acta. 1982; 713: 1
        • Rye K.-A.
        • Barter P.J.
        Changes in the size and density of human high-density lipoproteins promoted by a plasmaconversion factor.
        Biochim. Biophys. Acta. 1986; 875: 429
        • Clifton P.M.
        • Mackinnon A.M.
        • Barter P.J.
        Effects of serum amyloid A protein (SAA) on composition, size, and density of high density lipoproteins in subjects with myocardial infarction.
        J. Lipid Res. 1985; 26: 1389
        • Glomset J.A.
        The plasma lecithin: cholesterol acyltransferase reaction.
        J. Lipid Res. 1968; 9: 155
        • Fielding C.J.
        • Fielding P.E.
        Purification and substrate reactivity of lecithin-cholesterol acyltransferase from human plasma.
        FEBS Lett. 1971; 15: 355
        • Barter P.J.
        • Hopkins G.J.
        • Gorjatschko L.
        • Jones M.E.
        Competitive inhibition of plasma cholesterol esterification by human high-density lipoprotein subfraction-2.
        Biochim Biophys. Acta. 1984; 793: 260
        • Barter P.J.
        • Hopkins G.J.
        • Gorjatschko L.
        Lipoprotein substrates for plasma cholesterol esterification.
        Atherosclerosis. 1985; 58: 97
        • Miller G.J.
        • Miller N.E.
        Plasma-high-density-lipoprotein concentration and development of ischaemic heart disease.
        Lancet. 1975; i: 16
        • Nichols A.V.
        Human serum lipoproteins and their interrelationships.
        Adv. Biol. Med. Phys. 1967; 11: 109
        • Kunitake S.T.
        • La Sala K.J.
        • Kane J.P.
        Apoli-poprotein A-I-containing lipoproteins with pre-beta elect trophoretic mobility.
        J. Lipid Res. 1985; 26: 549
        • Borresen A.L.
        • Berg K.
        Presence of “free” apoA-I in serum: implications for immunological quantification of HDL and its apoproteins.
        Artery. 1980; 7: 139
        • Ishida B.Y.
        • Frolich J.
        • Fielding C.J.
        Prebeta-migrating high density lipoprotein: quantitation in normal and hyperlipidemic plasma by solid phase radioimmunoassay following electrophoretic transfer.
        J. Lipid Res. 1987; 28: 778
        • Eisenberg S.
        High density lipoprotein metabolism.
        J. Lipid Res. 1984; 25: 1017
        • Hatch F.T.
        • Lees R.S.
        Practical methods for plasma lipoprotein analysis.
        Adv. Lipid Res. 1968; 6: 1
        • Huff M.W.
        • Fidge N.H.
        • Nestel P.J.
        • Billington T.
        • Watson B.
        Metabolism of C-apolipoproteins: kinetics of C-II, C-IIII and C-III2, and VLDL-apolipoprotein B in normal and hyperlipoproteinemic subjects.
        J. Lipid Res. 1981; 22: 1235
        • Scanu A.
        • Toth J.
        • Edelstein C.
        • Koga S.
        • Stiller E.
        Fractionation of human serum high density lipoprotein in urea solutions. Evidence for polypeptide heterogeneity.
        Biochemistry. 1969; 8: 3309
        • Glomset J.A.
        • Norum K.R.
        • King W.
        Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency: lipid composition and reactivity in vitro.
        J. Clin. Invest. 1970; 49: 1827
        • Stokke K.T.
        • Norum K.R.
        Determination of lecithin: cholesterol acyltransferase inhuman blood plasma.
        Scand. J. Clin. Lab. Invest. 1971; 27: 21
        • Hopkins G.J.
        • Barter P.J.
        Dissociation of the in vitro transfers of esterified cholesterol and triglyceride between human lipoproteins.
        Metabolism. 1982; 31: 78
        • Hopkins G.J.
        • Barter P.J.
        Capacity of lipoproteins to act as substrates for lecithin: cholesterol acyltransferase. Enhancement by pre-incubation with an artificial triacylglycerol emulsion.
        Biochim. Biophys. Acta. 1984; 794: 31
        • Rajaram O.V.
        • Barter P.J.
        Increases in the particle size of high-density lipoproteins induced by purified lecithin: cholesterol acyltransferase: effect of low-density lipoproteins.
        Biochim. Biophys. Acta. 1986; 877: 406
        • Hopkins G.J.
        • Barter P.J.
        Role of triglyceride-rich lipoproteins and hepatic lipase in determining the particle size and composition of high density lipoproteins.
        J. Lipid Res. 1986; 27: 1265
        • Kunitake S.T.
        • Kane J.P.
        Factors affecting the integrity of high density lipoproteins in the ultracentrifuge.
        J. Lipid Res. 1982; 23: 936
        • Lefevre M.
        • Chuang M.Y.
        • Roheirn P.S.
        ApoA-IV metabolism in the rat: role of lipoprotein lipase and apolipoprotein transfer.
        J. Lipid Res. 1986; 27: 1163
        • Son Y.S.C.
        • Zilversmit D.B.
        Purification and characterization of human plasma proteins that inhibit lipid transfer activities.
        Biochim. Biophys. Acta. 1984; 795: 473
        • Parks J.S.
        • Martin L.A.
        • Johnson F.L.
        • Rudel L.L.
        Fusion of low density lipoproteins with cholesterol esterphospholipid microemulsions. Prevention of particle fusion by apolipoprotein A-I.
        J. Biol. Chem. 1985; 260: 3155
        • Nichols A.V.
        • Gong E.L.
        • Blanche P.J.
        • Forte T.M.
        • Shore V.G.
        Pathways in the formation of human plasma high density lipoprotein subpopulations containing apolipoprotein A-I without apolipoprotein A-II.
        J. Lipid Res. 1987; 28: 719